GNRSU Stock Crashes 99.99% on Pink Sheets, Greenrose Holdings Faces Delisting Risk

GNRSU stock has collapsed to near-zero levels, trading at just $0.000001 USD on the OTC Pink Sheets exchange as of May 13, 2026. The Greenrose Holding Company Inc., a New York-based cannabis cultivator and processor, has experienced a devastating 99.99% decline from its previous close of $0.15. This catastrophic drop reflects severe operational and financial distress. The company, which went public in February 2020, now faces existential challenges including microscopic trading volume of just 145 shares and a market capitalization of only $13. GNRSU stock represents one of the most extreme penny stock collapses in recent market history, signaling potential bankruptcy or delisting proceedings ahead.

GNRSU Stock Price Collapse and Trading Metrics

The GNRSU stock price has reached penny stock oblivion. Trading at $0.000001, the stock has lost virtually all shareholder value in what appears to be a catastrophic market event. The 52-week high of $0.151 now seems like ancient history compared to the current microscopic valuation.

Trading activity has dried up completely. Daily volume stands at just 145 shares, indicating virtually no liquidity or buyer interest. The bid-ask spread is likely enormous, making any exit nearly impossible for remaining shareholders. With 12.85 million shares outstanding, the total market capitalization sits at just $13, making GNRSU stock essentially worthless on paper.

Financial Deterioration and Balance Sheet Crisis

Greenrose Holdings faces severe balance sheet deterioration that explains the stock collapse. The company shows negative working capital of $103.4 million, indicating it cannot cover short-term obligations with current assets. Tangible asset value is deeply negative at $116.3 million, suggesting liabilities far exceed tangible resources.

The debt-to-equity ratio of 1.57 reveals heavy leverage, while the current ratio of just 0.21 signals acute liquidity stress. With only $0.56 cash per share and negative net current asset value of $142.5 million, the company appears insolvent. These metrics explain why GNRSU stock has become essentially worthless and why investors should treat this as a potential total loss situation.

Cannabis Industry Headwinds and Operational Challenges

Greenrose operates in the highly regulated cannabis sector, classified under Drug Manufacturers – Specialty & Generic. The company cultivates, processes, and packages medical cannabis products from its Amityville, New York headquarters with 910 full-time employees. However, regulatory pressures, banking restrictions, and federal illegality have crippled the entire sector.

The company’s inventory turnover of just 0.83 times annually suggests massive inventory buildup and potential obsolescence. Days of inventory outstanding reaches 439 days, indicating products sit in warehouses for over a year. This operational inefficiency, combined with cannabis market saturation and regulatory uncertainty, has destroyed shareholder value. Track GNRSU on Meyka for real-time updates on this distressed security.

Market Sentiment and Trading Activity

Trading Activity: GNRSU stock shows virtually no trading interest. The 145-share daily volume represents complete market abandonment. No institutional investors or serious traders are willing to accumulate shares at any price level, even at fractions of a penny.

Liquidation Pressure: The stock’s collapse suggests forced liquidation or bankruptcy proceedings may be underway. With negative tangible assets and massive working capital deficits, creditors likely have claims exceeding company value. Remaining shareholders face potential total loss, as secured creditors will be paid first in any restructuring or liquidation scenario.

Final Thoughts

GNRSU stock has collapsed 99.99% due to fundamental insolvency, negative tangible assets of $116.3 million, and massive debt. The cannabis company faces regulatory challenges, operational failures, and evaporated trading volume. Meyka AI’s B rating reflects outdated data. Investors should treat GNRSU as a total loss and avoid exposure entirely. Delisting and bankruptcy appear imminent, making this a cautionary example of extreme penny stock risk.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.